T1	Treatment 10 23	sulfasalazine
T2	Treatment 452 556	sulfasalazine, an inhibitor of NFÎºB, and placebo in a randomized, double-blind, crossover study design.
T3	Treatment 557 631	Brachial artery flow-mediated dilation (FMD) and digital vascular function
T4	Treatment 947 963	of sulfasalazine
T5	Treatment 1344 1367	long-term sulfasalazine
T6	Treatment 1379 1403	Short-term sulfasalazine
